ArticleFrontiers in oncology2025

Efficacy comparison of toripalimab versus pembrolizumab in neoadjuvant treatment of breast cancer: impact of chemotherapy regimen and sequence on pathologic complete response.

Yunjiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.